Inventor · disambiguated record
Gregory S. Robinson
Also filed as: ROBINSON GREGORY · ROBINSON GREGORY S · ROBINSON GREGORY SCOTT
15 granted patents·11 pending applications·665 citations·filing 1993–2023
94Inventor score
Top patents by PatentIndex Score
26 records- 0197US5814620AInhibition of neovascularization using vegf-specific oligonucleotidesHYBRIDON INC·Filed 1995·Granted Sep 29, 1998·329 cites·8 claims
- 0286US5639872AHuman VEGF-specific oligonucleotidesHYBRIDON INC·Filed 1995·Granted Jun 17, 1997·54 cites·1 claims
- 0383US11116852B2Frataxin expression constructsPRECIGEN INC·Filed 2017·Granted Sep 14, 2021·2 cites·23 claims
- 0483US5801156AInhibition of neovascularization using VEGF-specific oligonucleotidesHYBRIDON INC·Filed 1995·Granted Sep 1, 1998·45 cites·8 claims
- 0582US6410322B1Antisense oligonucleotide inhibition of vascular endothelial growth factor expressionHYBRIDON INC·Filed 1993·Granted Jun 25, 2002·44 cites·10 claims
- 0682US5661135AHuman VEGF-specific oligonucleotidesHYBRIDON INC·Filed 1995·Granted Aug 26, 1997·43 cites·12 claims
- 0782US5639736AHuman VEGF-specific oligonucleotidesHYBRIDON INC·Filed 1995·Granted Jun 17, 1997·42 cites·1 claims
- 0878US5710136AInhibition of neovascularization using VEGF-specific oligonucleotidesHYBRIDON INC·Filed 1995·Granted Jan 20, 1998·33 cites·8 claims
- 0975US2024000973A1Frataxin expression constructsPRECIGEN INC·Filed 2023·Application pending·0 cites
- 1072US5641756AModified VEGF oligonucleotidesHYBRIDON INC·Filed 1995·Granted Jun 24, 1997·32 cites·25 claims
- 1169US6399586B1Modified VEGF oligonucleotidesHYBRIDON INC·Filed 1999·Granted Jun 4, 2002·18 cites·8 claims
- 1268US2023149566A1Compositions and methods for treating macular dystrophyUNIV OXFORD INNOVATION LTD·Filed 2022·Application pending·0 cites
- 1367US11998618B2Frataxin expression constructsPRECIGEN INC·Filed 2020·Granted Jun 4, 2024·0 cites·21 claims
- 1464US6649596B1Modified VEGF Oligonucleotides for Inhibition of tumor growthHYBRIDON INC·Filed 1998·Granted Nov 18, 2003·17 cites·8 claims
- 1562US2025288692A1Compositions and methods for treating kcnq4-associated hearing lossAKOUOS INC·Filed 2022·Application pending·0 cites
- 1658US2023212606A1Compositions and methods for treating kcnq4-associated hearing lossAKOUOS INC·Filed 2021·Application pending·0 cites
- 1755US2019307900A1Compositions and methods for treating macular dystrophyUNIV OXFORD INNOVATION LTD·Filed 2019·Application pending·0 cites
- 1853US2021348193A1Compositions and methods for treating retinitis pigmentosaNIGHTSTARX LTD·Filed 2019·Application pending·0 cites
- 1949US2021147870A1Compositions and methods for the treatment of stargardt diseaseNIGHTSTARX LTD·Filed 2019·Application pending·0 cites
- 2044US5731294AInhibition of neovasularization using VEGF-specific oligonucleotidesHYBRIDON INC·Filed 1995·Granted Mar 24, 1998·6 cites·9 claims
- 2142US2005260651A1Enhanced biologically active conjugatesCALIAS PERICLES·Filed 2005·Application pending·0 cites
- 2241US2020341015A1Prenylation assayNIGHTSTARX LTD·Filed 2018·Application pending·0 cites
- 2339US2006019298A1Sequencing of modified nucleic acid moleculesSHIMA DAVID T·Filed 2005·Application pending·0 cites
- 2438US2006286636A1VEGF variantsSHIMA DAVID T·Filed 2006·Application pending·0 cites
- 2531US7785784B2Detection of oligonucleotides by dual hybridizationEYETECH INC·Filed 2005·Granted Aug 31, 2010·0 cites·43 claims
- 2629US6306829B1Modified VEGF oligonucleotides for treatment of skin disordersHYBRIDON INC·Filed 1996·Granted Oct 23, 2001·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Gregory S. Robinson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →